Q4 2025 Management View CEO Lawrence Bruno highlighted that "Core continued to execute its strategic plan of technology investments, targeted to both solve client problems and capitalize on Core's ...

Core Laboratories (NYSE:CLB) reported fourth-quarter and full-year 2025 results that reflected modest top-line growth, continued shareholder returns, and a mix of strength in international demand ...

(1) Three months ended September 30, 2024 includes reversals of stock compensation expense previously recognized due to a change in probability of performance condition for certain executive's share ...

HOUSTON, Feb. 4, 2026 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported fourth quarter 2025 revenue of $138,300,000 ...

HOUSTON, July 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported second quarter 2025 revenue of ...

Operator: Good day and welcome to the Core Laboratories Third Quarter 2023 Earnings Conference Call. [Operator instructions] After today’s presentation, there will be an opportunity to ask questions.

HOUSTON, May 7, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") is pleased to announce the opening of its new Unconventional Core Analysis Laboratory ...

HOUSTON (AP) — HOUSTON (AP) — Core Laboratories Inc. (CLB) on Wednesday reported net income of $7.1 million in its fourth quarter. The Houston-based company said it had profit of 15 cents per share.

The laboratory work Core Lab provides is used to ensure that the injection water is compatible with both the reservoir rocks and reservoir fluids. The water used for injection programs must undergo ...

probability of performance condition for certain executive's share awards. (2) Three months ended June 30, 2025 and September 30, 2025 includes the write-down of inventory. (3) Three months ended June ...